Biome Diagnostics GmbH (BiomeDx) is an Austrian MedTech company founded in 2018, specializing in AI-driven analysis of the gut microbiome. The company develops pioneering microbiome-based technologies for preventive health and precision medicine, offering both a lifestyle product (myBioma) and medically certified diagnostic tests for cancer care. Leveraging state-of-the-art DNA sequencing and machine learning, BiomeDx transforms complex microbiome data into actionable insights for individuals and healthcare professionals.